Lv5
920 积分 2024-11-19 加入
Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging
2天前
已完结
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
2天前
已完结
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going
4天前
已完结
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
4天前
已完结
Synthesis and preclinical evaluation of 68Ga-labeled PSMA tracers with improved pharmacological properties
6天前
已完结
Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers
6天前
已完结
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
9天前
已完结
Improving Theranostic Gallium-68/Lutetium-177-Labeled PSMA Inhibitors with an Albumin Binder for Prostate Cancer
9天前
已完结
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
9天前
已完结
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen
10天前
已完结
皖公网安备34019202002308
